← Evidence map

TrialPsychopharmacology2022

Efficacy and safety of aripiprazole once-monthly versus oral aripiprazole in Chinese patients with acute schizophrenia: a multicenter, randomized, double-blind, non-inferiority study.

Le Xiao et al.PubMed ↗Publisher ↗

No numbers read from the abstract.

9 papers cite it

2022
2023
2024
2025
this paperpooled itcites it

The trial

Full record →Abstract, authors, funding and every citing paper · PMID 34989824